share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities

輝瑞 | 4：持股變動聲明
SEC announcement ·  03/19 06:41
牛牛AI助理已提取核心訊息
Albert Bourla, Chairman & CEO of Pfizer Inc. (PFE), has engaged in a transaction involving the company's stock on March 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As a result, the number of shares Bourla holds after the action remains unknown.
Albert Bourla, Chairman & CEO of Pfizer Inc. (PFE), has engaged in a transaction involving the company's stock on March 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. As a result, the number of shares Bourla holds after the action remains unknown.
輝瑞公司（PFE）董事長兼首席執行官艾伯特·布爾拉於2024年3月15日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。因此，Bourla在行動後持有的股票數量仍然未知。
輝瑞公司（PFE）董事長兼首席執行官艾伯特·布爾拉於2024年3月15日參與了一項涉及該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。也沒有提供交易的操作類型和狀態。因此，Bourla在行動後持有的股票數量仍然未知。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。